Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Pfizer announces agreement with Gilead to manufacture remdesivir » 08:05
08/07/20
08/07
08:05
08/07/20
08:05
PFE

Pfizer

$38.27 /

-0.18 (-0.47%)

, GILD

Gilead

$68.80 /

-0.19 (-0.28%)

Pfizer (PFE) said in a…

Pfizer (PFE) said in a release, "Pfizer announced a multi-year agreement with Gilead Sciences (GILD) to manufacture and supply Gilead's investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for COVID-19. Under the terms of the agreement, Pfizer will provide contract manufacturing services at Pfizer's McPherson, Kansas facility to manufacture and supply remdesivir for Gilead. In March, Pfizer launched a five-point plan, which called on all members of the innovation ecosystem - from large pharmaceutical companies to the smallest of biotech companies, from government agencies to academic institutions - to commit to work together in addressing the dire COVID-19 crisis."

ShowHide Related Items >><<
PFE Pfizer
$38.27 /

-0.18 (-0.47%)

GILD Gilead
$68.80 /

-0.19 (-0.28%)

PFE Pfizer
$38.27 /

-0.18 (-0.47%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
GILD Gilead
$68.80 /

-0.19 (-0.28%)

08/03/20 Citi
Gilead price target raised to $80 from $78 at Citi
07/31/20 Wells Fargo
Gilead price target lowered to $76 from $87 at Wells Fargo
07/30/20 Piper Sandler
Gilead price target lowered to $85 from $90 at Piper Sandler
07/28/20 Piper Sandler
Piper Sandler lowers FY20, FY21 earnings forecasts for Gilead
PFE Pfizer
$38.27 /

-0.18 (-0.47%)

GILD Gilead
$68.80 /

-0.19 (-0.28%)

PFE Pfizer
$38.27 /

-0.18 (-0.47%)

GILD Gilead
$68.80 /

-0.19 (-0.28%)

PFE Pfizer
$38.27 /

-0.18 (-0.47%)

GILD Gilead
$68.80 /

-0.19 (-0.28%)

PFE Pfizer
$38.27 /

-0.18 (-0.47%)

GILD Gilead
$68.80 /

-0.19 (-0.28%)

Thursday
Periodicals
Trump to order government to buy certain drugs from U.S., USA Today says » 10:12
08/06/20
08/06
10:12
08/06/20
10:12
JNJ

Johnson & Johnson

$148.29 /

-0.1 (-0.07%)

, LLY

Eli Lilly

$154.75 /

+0.36 (+0.23%)

, MRK

Merck

$81.48 /

-0.13 (-0.16%)

, PFE

Pfizer

$38.73 /

+0.28 (+0.73%)

, SNY

Sanofi

$51.41 /

-0.27 (-0.52%)

, AZN

AstraZeneca

$56.22 /

+0.3 (+0.54%)

, GSK

GlaxoSmithKline

$41.04 /

-0.17 (-0.41%)

, NVS

Novartis

$83.51 /

+0.07 (+0.08%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$61.67 /

+1.98 (+3.32%)

President Donald Trump…

President Donald Trump will sign an executive order mandating the federal government to buy certain drugs from U.S. manufacturers rather than foreign companies, USA Today's Michael Collins reports, citing officials. The order, which will be signed at Whirlpool's (WHR) manufacturing facility in Ohio, requires the government to develop a list of "essential" medicines and purchase them as well as other medical supplies from the U.S. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Reference Link

ShowHide Related Items >><<
SNY Sanofi
$51.41 /

-0.27 (-0.52%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$38.73 /

+0.28 (+0.73%)

NVS Novartis
$83.51 /

+0.07 (+0.08%)

MRK Merck
$81.48 /

-0.13 (-0.16%)

LLY Eli Lilly
$154.75 /

+0.36 (+0.23%)

JNJ Johnson & Johnson
$148.29 /

-0.1 (-0.07%)

GSK GlaxoSmithKline
$41.04 /

-0.17 (-0.41%)

BMY Bristol-Myers
$61.67 /

+1.98 (+3.32%)

AZN AstraZeneca
$56.22 /

+0.3 (+0.54%)

JNJ Johnson & Johnson
$148.29 /

-0.1 (-0.07%)

07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20 Goldman Sachs
J&J valuation discount to S&P 500 'too wide,' says Goldman Sachs
07/17/20 Citi
Johnson & Johnson price target raised to $170 from $165 at Citi
LLY Eli Lilly
$154.75 /

+0.36 (+0.23%)

07/31/20 Barclays
Eli Lilly earnings selloff 'meaningful over-reaction,' says Barclays
07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
MRK Merck
$81.48 /

-0.13 (-0.16%)

08/04/20 Piper Sandler
Merck deal sparks interest in GLP-1:glucagon agonists, says Piper Sandler
08/03/20
Fly Intel: Top five analyst upgrades
08/03/20 Goldman Sachs
Merck upgraded to Buy from Neutral at Goldman Sachs
PFE Pfizer
$38.73 /

+0.28 (+0.73%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
SNY Sanofi
$51.41 /

-0.27 (-0.52%)

07/31/20 JPMorgan
Sanofi price target raised to EUR 106 from EUR 103 at JPMorgan
07/20/20 BMO Capital
Immunic initiated with an Outperform at BMO Capital
07/08/20 Piper Sandler
Piper upgrades Kiadis on 'platform validating' Sanofi deal
07/06/20 Citi
BioMarin price target raised to $148 from $105 at Citi
AZN AstraZeneca
$56.22 /

+0.3 (+0.54%)

07/31/20 Barclays
Barclays backs Overweight on AstraZeneca after Q2 results
07/29/20 Barclays
AstraZeneca price target raised to 9,300 GBp from 9,200 GBp at Barclays
GSK GlaxoSmithKline
$41.04 /

-0.17 (-0.41%)

07/31/20 Barclays
Barclays backs Underweight on GSK after 'challenging' Q2
07/30/20 Roth Capital
Roth Capital bullish on Ideaya as GSK highlights synthetic lethality pipeline
07/13/20 UBS
UBS reiterates Buy on GSK as FDA belantamab docs are out
07/13/20 JPMorgan
Ideaya upgraded to Overweight on recent pullback at JPMorgan
NVS Novartis
$83.51 /

+0.07 (+0.08%)

07/28/20 Morgan Stanley
Novartis price target raised to CHF 93 from CHF 91 at Morgan Stanley
07/01/20 Piper Sandler
Amgen appeal rules in favor of patent validity, says Piper Sandler
07/01/20 Jefferies
Amgen win on Enbrel patent removes key overhang, says Jefferies
07/01/20 Goldman Sachs
Global Blood Therapeutics upgraded to Buy from Neutral at Goldman Sachs
RHHBY Roche
$0.00 /

+ (+0.00%)

07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
BMY Bristol-Myers
$61.67 /

+1.98 (+3.32%)

08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
07/28/20 Raymond James
Bristol-Myers initiated with an Outperform at Raymond James
SNY Sanofi
$51.41 /

-0.27 (-0.52%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$38.73 /

+0.28 (+0.73%)

NVS Novartis
$83.51 /

+0.07 (+0.08%)

MRK Merck
$81.48 /

-0.13 (-0.16%)

LLY Eli Lilly
$154.75 /

+0.36 (+0.23%)

JNJ Johnson & Johnson
$148.29 /

-0.1 (-0.07%)

GSK GlaxoSmithKline
$41.04 /

-0.17 (-0.41%)

BMY Bristol-Myers
$61.67 /

+1.98 (+3.32%)

AZN AstraZeneca
$56.22 /

+0.3 (+0.54%)

SNY Sanofi
$51.41 /

-0.27 (-0.52%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$38.73 /

+0.28 (+0.73%)

NVS Novartis
$83.51 /

+0.07 (+0.08%)

MRK Merck
$81.48 /

-0.13 (-0.16%)

LLY Eli Lilly
$154.75 /

+0.36 (+0.23%)

JNJ Johnson & Johnson
$148.29 /

-0.1 (-0.07%)

GSK GlaxoSmithKline
$41.04 /

-0.17 (-0.41%)

AZN AstraZeneca
$56.22 /

+0.3 (+0.54%)

SNY Sanofi
$51.41 /

-0.27 (-0.52%)

RHHBY Roche
$0.00 /

+ (+0.00%)

NVS Novartis
$83.51 /

+0.07 (+0.08%)

MRK Merck
$81.48 /

-0.13 (-0.16%)

LLY Eli Lilly
$154.75 /

+0.36 (+0.23%)

JNJ Johnson & Johnson
$148.29 /

-0.1 (-0.07%)

GSK GlaxoSmithKline
$41.04 /

-0.17 (-0.41%)

BMY Bristol-Myers
$61.67 /

+1.98 (+3.32%)

AZN AstraZeneca
$56.22 /

+0.3 (+0.54%)

SNY Sanofi
$51.41 /

-0.27 (-0.52%)

PFE Pfizer
$38.73 /

+0.28 (+0.73%)

NVS Novartis
$83.51 /

+0.07 (+0.08%)

MRK Merck
$81.48 /

-0.13 (-0.16%)

LLY Eli Lilly
$154.75 /

+0.36 (+0.23%)

JNJ Johnson & Johnson
$148.29 /

-0.1 (-0.07%)

GSK GlaxoSmithKline
$41.04 /

-0.17 (-0.41%)

BMY Bristol-Myers
$61.67 /

+1.98 (+3.32%)

AZN AstraZeneca
$56.22 /

+0.3 (+0.54%)

Recommendations
BioNTech price target raised to $69 from $42 at SVB Leerink » 09:37
08/06/20
08/06
09:37
08/06/20
09:37
BNTX

BioNTech

$81.28 /

-1.89 (-2.27%)

SVB Leerink analyst Daina…

SVB Leerink analyst Daina Graybosch raised the firm's price target on BioNTech to $69 from $42 as the analyst reassesses the global opportunity for COVID-19 vaccines. Graybosch keeps a Market Perform rating on the shares.

ShowHide Related Items >><<
BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/21/20
Fly Intel: Top five analyst upgrades
BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

  • 23
    Jul
  • 06
    Feb
  • 10
    Oct
BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

Hot Stocks
Bristol-Myers reports district court upheld Eliquis patents » 07:23
08/06/20
08/06
07:23
08/06/20
07:23
BMY

Bristol-Myers

$59.69 /

+0.26 (+0.44%)

, PFE

Pfizer

$38.45 /

+0.07 (+0.18%)

In August, the…

In August, the Bristol-Myers Squibb-Pfizer Alliance announced the U.S. District Court decision to uphold both the composition of matter patent, US 6,967,208, and formulation patent, US 9,326,945, covering Eliquis, Bristol noted along with its earnings report.

ShowHide Related Items >><<
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
07/28/20 Raymond James
Bristol-Myers initiated with an Outperform at Raymond James
07/22/20 Morgan Stanley
Morgan Stanley sees 'encouraging news' coming in near-term for Bristol-Myers
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

Recommendations
Moderna COVID vaccine still has 'best-in-class potential,' says Barclays » 06:59
08/06/20
08/06
06:59
08/06/20
06:59
MRNA

Moderna

$75.76 /

-2.72 (-3.47%)

, NVAX

Novavax

$173.38 /

+16.23 (+10.33%)

Barclays analyst Gena…

Barclays analyst Gena Wang raised the firm's price target on Moderna (MRNA) to $84 from $68 and keeps an Overweight rating on the shares. The stock closed Wednesday down $2.66 to $75.50. The company's Q2 update highlighted pipeline progress including mRNA-1273 Phase 3 trial enrollment for COVID-19 completion by the end of September, Wang tells investors in a research note. Approximately $400M customer deposits were received as of July 31 for commercial supply of mRNA-1273, and discussions with countries are ongoing, the analyst points out. While Novavax's (NVAX) vaccine data were encouraging, the high neutralizing titers in the mRNA-1273 Phase 1 trial continue to support mRNA-1273's "best-in-class potential," Wang contends.

ShowHide Related Items >><<
NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
NVAX Novavax
$173.38 /

+16.23 (+10.33%)

08/06/20 H.C. Wainwright
Novavax price target raised to $290 from $132 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst downgrades
08/05/20
Fly Intel: Top five analyst upgrades
08/05/20 B. Riley FBR
Novavax price target raised to $257 from $184 at B. Riley FBR
NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

  • 19
    May
  • 12
    Feb
NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

Periodicals
Early Covid vaccine supplies likely to fall short of what is needed, WSJ reports » 06:18
08/06/20
08/06
06:18
08/06/20
06:18
MRNA

Moderna

$75.76 /

-2.72 (-3.47%)

, PFE

Pfizer

$38.45 /

+0.07 (+0.18%)

, NVAX

Novavax

$173.38 /

+16.23 (+10.33%)

, AZN

AstraZeneca

$55.92 /

-0.145 (-0.26%)

Initial supplies of any…

Initial supplies of any successful coronavirus vaccines are now expected to fall short of what is needed, The Wall Street Journal's Peter Loftus reports. Public-health officials estimate more than 100 million Americans, including doctors and nurses, other essential workers and nursing-home residents, should get vaccinated before the general public, but there may only be 10 million to 20 million doses available at first, according to a slide presentation prepared by the U.S. Centers for Disease Control and Prevention staff and shown to a committee of outside vaccine advisers last week. Companies including Moderna (MRNA), AstraZeneca (AZN), Pfizer (PFE) and Novavax (NVAX) have started large clinical trials of their vaccine candidates. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
NVAX Novavax
$173.38 /

+16.23 (+10.33%)

08/05/20
Fly Intel: Top five analyst downgrades
08/05/20
Fly Intel: Top five analyst upgrades
08/05/20 B. Riley FBR
Novavax price target raised to $257 from $184 at B. Riley FBR
08/05/20 Cantor Fitzgerald
Novavax price target raised to $211 from $148 at Cantor Fitzgerald
AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

07/31/20 Barclays
Barclays backs Overweight on AstraZeneca after Q2 results
07/29/20 Barclays
AstraZeneca price target raised to 9,300 GBp from 9,200 GBp at Barclays
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

  • 19
    May
  • 12
    Feb
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

Conference/Events
Moderna participates in a conference call with Oppenheimer » 04:55
08/06/20
08/06
04:55
08/06/20
04:55
MRNA

Moderna

$75.76 /

-2.72 (-3.47%)

Conference call with…

Conference call with management will be held on August 6 hosted by Oppenheimer.

ShowHide Related Items >><<
MRNA Moderna
$75.76 /

-2.72 (-3.47%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
MRNA Moderna
$75.76 /

-2.72 (-3.47%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$75.76 /

-2.72 (-3.47%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

Wednesday
On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 17:41
08/05/20
08/05
17:41
08/05/20
17:41
DIS

Disney

$127.64 /

+10.185 (+8.67%)

, CVS

CVS Health

$64.44 /

-0.55 (-0.85%)

, NVAX

Novavax

$173.38 /

+16.23 (+10.33%)

, JNJ

Johnson & Johnson

$148.39 /

+1.19 (+0.81%)

, PFE

Pfizer

$38.45 /

+0.07 (+0.18%)

, BNTX

BioNTech

$81.28 /

-1.89 (-2.27%)

, MRNA

Moderna

$75.76 /

-2.72 (-3.47%)

, TDOC

Teladoc

$202.21 /

-46.9 (-18.83%)

, LVGO

Livongo Health

$128.16 /

-16.32 (-11.30%)

, XOM

Exxon Mobil

$43.84 /

+0.36 (+0.83%)

, CI

Cigna

$175.07 /

+1.53 (+0.88%)

, FLGT

Fulgent Genetics

$35.97 /

+6.29 (+21.19%)

, ENLC

EnLink Midstream

$2.99 /

+0.455 (+17.95%)

, LPSN

LivePerson

$56.16 /

+9.91 (+21.43%)

, AIZ

Assurant

$122.40 /

+15.32 (+14.31%)

, EVER

EverQuote

$41.61 /

-12.64 (-23.30%)

, VAPO

Vapotherm

$32.87 /

-20.59 (-38.51%)

, NEWR

New Relic

$55.85 /

-17.655 (-24.02%)

, CDLX

Cardlytics

$66.08 /

-6.6 (-9.08%)

The S&P had its fourth…

Open Full Text

ShowHide Related Items >><<
XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

NEWR New Relic
$55.85 /

-17.655 (-24.02%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

FLGT Fulgent Genetics
$35.97 /

+6.29 (+21.19%)

EVER EverQuote
$41.61 /

-12.64 (-23.30%)

ENLC EnLink Midstream
$2.99 /

+0.455 (+17.95%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

AIZ Assurant
$122.40 /

+15.32 (+14.31%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

08/05/20
Fly Intel: Top five analyst upgrades
08/05/20 JPMorgan
Disney remains top pick in media post Q3 results at JPMorgan
08/05/20 Needham
Needham says still 'too early' to buy Disney, keeps Hold rating after earnings
08/05/20 BMO Capital
Disney price target raised to $150 from $140 at BMO Capital
CVS CVS Health
$64.44 /

-0.55 (-0.85%)

08/06/20 Deutsche Bank
CVS Health price target lowered to $104 from $109 at Deutsche Bank
07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/01/20 SVB Leerink
CVS Health reinstated with a Market Perform at SVB Leerink
06/01/20 Stephens
Molina Healthcare price target raised to $215 from $202 at Stephens
NVAX Novavax
$173.38 /

+16.23 (+10.33%)

08/06/20 Barclays
Moderna COVID vaccine still has 'best-in-class potential,' says Barclays
08/06/20 H.C. Wainwright
Novavax price target raised to $290 from $132 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20 Goldman Sachs
J&J valuation discount to S&P 500 'too wide,' says Goldman Sachs
07/17/20 Citi
Johnson & Johnson price target raised to $170 from $165 at Citi
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

07/21/20
Fly Intel: Top five analyst upgrades
MRNA Moderna
$75.76 /

-2.72 (-3.47%)

08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

08/06/20 Deutsche Bank
Teladoc price target lowered to $225 from $238 at Deutsche Bank
08/06/20 Needham
Livongo Health downgraded to Hold from Buy at Needham
08/06/20 Truist
Teladoc upgraded to Buy from Hold at Truist
08/06/20 Truist
Teladoc upgraded to Buy from Hold at Truist
LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

08/06/20 Needham
Livongo Health downgraded to Hold from Buy at Needham
08/05/20 Stifel
Stifel views Teledoc, Livongo as largely complementary businesses
XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

07/23/20 Truist
SunTrust starts Exxon with Hold rating, $41 price target
07/23/20 Truist
Exxon Mobil initiated with a Hold at SunTrust
06/09/20 Standpoint Research
Exxon Mobil downgraded to Hold from Buy at Standpoint Research
06/09/20 JPMorgan
Exxon Mobil price target raised to $51 from $44 at JPMorgan
CI Cigna
$175.07 /

+1.53 (+0.88%)

08/06/20 RBC Capital
Ontrak price target raised to $50 from $35 at RBC Capital
07/01/20 SVB Leerink
Cigna reinstated with a Market Perform at SVB Leerink
06/29/20 SVB Leerink
Inspire Medical price target raised to $110 from $85 at SVB Leerink
06/05/20 BMO Capital
Cigna price target raised to $242 from $215 at BMO Capital
FLGT Fulgent Genetics
$35.97 /

+6.29 (+21.19%)

08/05/20 Piper Sandler
Fulgent Genetics price target raised to $68 from $31 at Piper Sandler
07/27/20 Piper Sandler
Fulgent Genetics price target raised to $31 from $21 at Piper Sandler
06/17/20 Piper Sandler
Fulgent Genetics price target raised to $21 from $18 at Piper Sandler
05/29/20 BTIG
Fulgent Genetics initiated with a Buy at BTIG
ENLC EnLink Midstream
$2.99 /

+0.455 (+17.95%)

05/06/20 Mizuho
EnLink Midstream price target lowered to $2.50 from $7 at Mizuho
04/02/20 Credit Suisse
EnLink Midstream downgraded to Underperform from Neutral at Credit Suisse
03/24/20 Barclays
EnLink Midstream downgraded to Underweight from Equal Weight at Barclays
03/12/20 Raymond James
EnLink Midstream downgraded to Market Perform from Outperform at Raymond James
LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

08/05/20 B. Riley FBR
LivePerson price target raised to $63 from $49 at B. Riley FBR
08/05/20 Barclays
LivePerson price target raised to $64 from $49 at Barclays
08/05/20 Craig-Hallum
LivePerson price target raised to $60 from $34 at Craig-Hallum
08/05/20 Roth Capital
LivePerson price target raised to $75 from $53 at Roth Capital
AIZ Assurant
$122.40 /

+15.32 (+14.31%)

10/03/19 Truist
Assurant price target raised to $145 from $140 at SunTrust
EVER EverQuote
$41.61 /

-12.64 (-23.30%)

07/14/20 BofA
EverQuote downgraded to Underperform from Neutral at BofA
07/14/20 BofA
EverQuote downgraded to Underperform from Neutral at BofA
06/02/20 Oppenheimer
EverQuote price target raised to $65 from $50 at Oppenheimer
05/27/20 Canaccord
EverQuote price target raised to $60 from $50 at Canaccord
VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

07/13/20 BTIG
Vapotherm price target raised to $53 from $32 at BTIG
06/05/20 Canaccord
Vapotherm price target raised to $34 from $30 at Canaccord
05/06/20 Canaccord
Vapotherm price target raised to $30 from $20 at Canaccord
04/14/20 Canaccord
Vapotherm price target raised to $20 from $14 at Canaccord
NEWR New Relic
$55.85 /

-17.655 (-24.02%)

08/05/20 UBS
New Relic sales turnaround taking longer than expected, says UBS
08/05/20 JPMorgan
New Relic downgraded to Neutral on strategy change at JPMorgan
08/05/20 JPMorgan
New Relic downgraded to Neutral from Overweight at JPMorgan
08/04/20 BMO Capital
New Relic price target raised to $78 from $70 at BMO Capital
CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

08/05/20 Craig-Hallum
Cardlytics price target raised to $70 from $50 at Craig-Hallum
07/09/20 Truist
Cardlytics price target raised to $75 from $55 at SunTrust
05/12/20 Craig-Hallum
Cardlytics price target lowered to $50 from $70 at Craig-Hallum
05/12/20 Truist
Cardlytics price target raised to $55 from $50 at SunTrust
XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

NEWR New Relic
$55.85 /

-17.655 (-24.02%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

FLGT Fulgent Genetics
$35.97 /

+6.29 (+21.19%)

EVER EverQuote
$41.61 /

-12.64 (-23.30%)

ENLC EnLink Midstream
$2.99 /

+0.455 (+17.95%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

AIZ Assurant
$122.40 /

+15.32 (+14.31%)

  • 23
    Jul
  • 19
    May
  • 07
    May
  • 12
    Feb
  • 06
    Feb
  • 12
    Dec
  • 14
    Nov
  • 10
    Oct
  • 11
    Sep
XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

NEWR New Relic
$55.85 /

-17.655 (-24.02%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

FLGT Fulgent Genetics
$35.97 /

+6.29 (+21.19%)

ENLC EnLink Midstream
$2.99 /

+0.455 (+17.95%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

Hot Stocks
Moderna selects Amazon Web Services as preferred cloud provider » 17:01
08/05/20
08/05
17:01
08/05/20
17:01
MRNA

Moderna

$75.76 /

-2.72 (-3.47%)

, AMZN

Amazon.com

$3,205.41 /

+69.43 (+2.21%)

Amazon Web Services…

Amazon Web Services (AMZN) announced that Moderna (MRNA) has selected AWS as its preferred cloud provider, as well as its standard for analytics and machine learning workloads. Leveraging its mRNA platform and manufacturing facility with the AWS-powered research engine, Moderna delivered the first clinical batch of its vaccine candidate against COVID-19 to the NIH for the Phase 1 trial 42 days after the initial sequencing of the virus. By building and scaling its operations on the world's leading cloud, Moderna is able to quickly design research experiments and uncover new insights, automate its laboratory and manufacturing processes to enhance its drug discovery pipeline, and more easily comply with applicable laws and regulations during production and testing of vaccine and therapeutic candidates.

ShowHide Related Items >><<
MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AMZN Amazon.com
$3,205.41 /

+69.43 (+2.21%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
AMZN Amazon.com
$3,205.41 /

+69.43 (+2.21%)

08/03/20 Morgan Stanley
ADT Inc. price target raised to $17 from $7 at Morgan Stanley
07/31/20 BMO Capital
Amazon.com price target raised to $3,700 from $3,500 at BMO Capital
07/31/20 RBC Capital
Amazon.com price target raised to $3,800 from $3,300 at RBC Capital
07/31/20 Guggenheim
Amazon.com price target raised to $3,600 from $2,700 at Guggenheim
MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AMZN Amazon.com
$3,205.41 /

+69.43 (+2.21%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AMZN Amazon.com
$3,205.41 /

+69.43 (+2.21%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AMZN Amazon.com
$3,205.41 /

+69.43 (+2.21%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AMZN Amazon.com
$3,205.41 /

+69.43 (+2.21%)

AMZN Amazon.com
$3,205.41 /

+69.43 (+2.21%)

Conference/Events
Moderna participates in a conference call with Oppenheimer » 13:04
08/05/20
08/05
13:04
08/05/20
13:04
MRNA

Moderna

$75.14 /

-3.34 (-4.26%)

Conference call with…

Conference call with management will be held on August 6 hosted by Oppenheimer.

ShowHide Related Items >><<
MRNA Moderna
$75.14 /

-3.34 (-4.26%)

MRNA Moderna
$75.14 /

-3.34 (-4.26%)

08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
MRNA Moderna
$75.14 /

-3.34 (-4.26%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$75.14 /

-3.34 (-4.26%)

MRNA Moderna
$75.14 /

-3.34 (-4.26%)

MRNA Moderna
$75.14 /

-3.34 (-4.26%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.